[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![3rdFloorCapital Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1719523401037914112.png) Third Floor Capital [@3rdFloorCapital](/creator/twitter/3rdFloorCapital) on x XXX followers
Created: 2025-06-18 18:50:27 UTC

Sarepta Therapeutics (NASDAQ: $SRPT) is a commercial biotech company with drugs that treat DMD. Sarepta sells X types of treatments: Gene Therapy and PMOs. The stock fell more than XX% on Monday after the company disclosed their flagship Gene Therapy (ELEVIDYS) resulted in the death of a second non-ambulatory patient due to Acute Liver Failure. 2/


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1935409792962470299/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[$srpt](/topic/$srpt)
[nasdaq](/topic/nasdaq)
[sarepta therapeutics](/topic/sarepta-therapeutics)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/3rdFloorCapital/status/1935409792962470299)